Opens profile photo
Follow
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
Co-founder & CEO
@NeuroAgeTX
| Co-Founder & CEO
@SaveScience
&
@longevityGL
| #ODLB | Past:
@MIT
postdoc | CMU/Pitt MSTP (neuroscience)
San Francisco, CAdrglorioso.substack.comJoined July 2020
1,016 Following
1,030 Followers

Christin Glorioso, MD PhD🏳️‍🌈’s Tweets

Pinned Tweet
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
We are so excited to be winners of the MBC BioLabs Golden ticket! Can't wait to get to the bench in this wonderful community with a year of lab space.
Quote Tweet
MBC BioLabs
@MBiolabs
We are so proud to announce the winners of the MBC BioLabs Diversity Golden Ticket, supported by AbbVie: MabSwitch and NeuroAge Therapeutics! We cannot wait for these amazing companies to join our growing community! 🥳
Image
Image
Image
16
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
Regardless of what you think of the UK Royals, the Harry and Meghan doc is worth watching for the commentary on the press. It's just amazing how false outrage inducing narratives can be spun up for profit and what a threat that is to individual people and society.
4
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
2. "Joseph Mercola uses health disinformation to promote the sale of supplements, books and food. During the height of the pandemic, he promoted a new website designed to prevent or treat COVID-19 with alternative remedies. His business has a net worth of $100 million."
2
Show this thread
Christin Glorioso, MD PhD🏳️‍🌈 Retweeted
Matt Kaeberlein
@mkaeberlein
In 2020, chronic (age-related) disease afflicted 50% of the population, and consumed >85% of health care costs in the US. That number is growing. When does the system break down completely? 90%? 95%? We need to start treating the root cause of these diseases, before that happens
Image
24
328
Christin Glorioso, MD PhD🏳️‍🌈 Retweeted
Carlos Baquero
@xmal
Large scale surveys of health symptoms can provide quick insights during an epidemic, including changes in vaccine efficacy during the rise of new variants. Our new paper at
@SciReports
shows lessons learned during the Omicron Covid rise in early 2022.
nature.com
Using survey data to estimate the impact of the omicron variant on vaccine efficacy against...
Scientific Reports - Using survey data to estimate the impact of the omicron variant on vaccine efficacy against COVID-19 infection
4
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
4/n One way to get more accurate case counts is to use surveys on social media to ask people about symptoms. Machine learning can then infer true case numbers from symptoms that are specific to COVID vs. other respiratory diseases.
1
Show this thread
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
2/n Without accurate absolute case numbers from countries without sufficient testing or even fraudulent testing in some cases, it is impossible to create useful predictive COVID case models. So we need alternative ways to estimate true case numbers.
1
Show this thread
Christin Glorioso, MD PhD🏳️‍🌈 Retweeted
Longevity Global
@LongevityGL
An Iowa woman who was believed to be the oldest living person in the U.S. has died at the age of 115...Born in 1907, Hendricks was alive for the sinking of the Titanic, World War I and II, the Great Depression & both the Spanish flu and Covid-19 pandemics.
nbcnews.com
Iowa woman believed to be the oldest person in the U.S. dies at 115
Born in 1907, Bessie Hendricks was alive to witness news of the sinking of the Titanic, World Wars I and II, the Great Depression and both the Spanish flu and Covid-19 pandemics.
1
Christin Glorioso, MD PhD🏳️‍🌈
@DrGlorioso
Whoever started the whole "fishing expedition" thing had some serious flaws in their thinking. Nothing could be more scientific than unbiased screens.
Quote Tweet
Matt Kaeberlein
@mkaeberlein
This is a big limitation in the aging field today in my view. Too many people are looking under the lamppost. Few are exploring anything outside the hallmarks. You won't catch any fish if you never go fishing. youtube.com/watch?v=kkozY2
1
8
Christin Glorioso, MD PhD🏳️‍🌈 Retweeted
Longevity Global
@LongevityGL
"US regulators approved Eisai and Biogen’s Alzheimer’s drug lecanemab, a landmark moment for the disease and a second chance for the companies after their drug Aduhelm was a commercial flop in the face of cost and efficacy concerns."
endpts.com
Breaking: FDA clears second Alzheimer's drug in 'foundational spark' for field
US regulators approved Eisai and Biogen’s Alzheimer's drug lecanemab, a landmark moment for the disease and a second chance for the companies after their drug Aduhelm was a commercial flop in the...
1